Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities
- PMID: 37636496
- PMCID: PMC10450407
- DOI: 10.1016/j.gore.2023.101240
Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities
Abstract
Objective: To describe the surgical and oncologic outcomes in surgically treated oldest old women (≥80 years) with endometrioid endometrial cancer as a function of their comorbidities.
Methods: In this retrospective cohort study, patients aged 80-99 years who underwent surgical management of stage I endometrioid endometrial cancer between 2006 and 2018 were included. Low- and high-intermediate risk disease was defined using the Gynecologic Oncology Group-99 criteria. The validated, Combined Age-Charlson Comorbidity Index (CA-CCI) was used to quantify comorbidity burden. Logistic regression was used to identify the independent predictors of various surgical and oncologic outcomes. Kaplan-Meier survival analysis was performed to compare survival distributions based on mortality cause and comorbidity status.
Results: We identified 64 women who met the eligibility criteria. Median age was 84 years (IQR 80, 94 years). Among oldest old women undergoing a hysterectomy with or without lymph node dissection, women with a CA-CCI score of ≥7 had an 8 times higher risk of postoperative infections compared with oldest old women with a <7 score (95% CI 1.53-48.91, P = 0.015). Women with a CA-CCI score of ≥8 were 45% less likely to survive at 3 years (aRR 0.55, 95% CI 0.004-0.87; P = 0.039) than those with a lower CA-CCI score (three-year overall survival 73% vs 96%).
Conclusion: Surgical and oncologic outcomes in oldest old women with early stage endometrioid endometrial cancer are largely determined by comorbidity status. Less comorbid women (CA-CCI score < 8) had a significantly higher five-year survival at 87% than their more comorbid counterparts. Use of age-comorbidity risk scoring such as CA-CCI, preoperative optimization, and careful selection for and counseling of patients about surgical treatment are paramount in providing optimal recovery and survival advantages in the oldest old.
Keywords: Cancer survival; Comorbidity Index; Mortality; Older women; Postoperative outcomes; Uterine cancer.
© 2023 The Authors.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures



References
-
- Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I. Endometrial cancer. Lancet. 2005;366(9484):491–505. - PubMed
-
- Bentrem D.J., Cohen M.E., Hynes D.M., Ko C.Y., Bilimoria K.Y. Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch. Surg. 2009;144(11):1013–1020. - PubMed
-
- Casarin J., Multinu F., Tortorella L., Cappuccio S., Weaver A.L., Ghezzi F., Cliby W., Kumar A., Langstraat C., Glaser G., Mariani A. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes. Int. J. Gynecol. Cancer. 2020;30(1):41–47. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources